131 related articles for article (PubMed ID: 26610166)
1. Short-term oxycodone treatment does not affect electrogenic ion transport in isolated mucosa from the human rectosigmoid colon.
Nilsson M; Brock C; Poulsen JL; Bindslev N; Hansen MB; Louring Christrup L; Drewes AM
Scand J Gastroenterol; 2016; 51(5):538-47. PubMed ID: 26610166
[TBL] [Abstract][Full Text] [Related]
2. Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI.
Nilsson M; Poulsen JL; Brock C; Sandberg TH; Gram M; Frøkjær JB; Krogh K; Drewes AM
Eur J Gastroenterol Hepatol; 2016 May; 28(5):514-24. PubMed ID: 26795566
[TBL] [Abstract][Full Text] [Related]
3. Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers.
Mark EB; Nedergaard RB; Hansen TM; Nissen TD; Frøkjaer JB; Scott SM; Krogh K; Drewes AM
Neurogastroenterol Motil; 2021 Nov; 33(11):e14131. PubMed ID: 34051122
[TBL] [Abstract][Full Text] [Related]
4. MRI analysis of fecal volume and dryness: Validation study using an experimental oxycodone-induced constipation model.
Mark EB; Bødker MB; Grønlund D; Østergaard LR; Frøkjaer JB; Drewes AM
J Magn Reson Imaging; 2019 Sep; 50(3):733-745. PubMed ID: 30609164
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.
Kaltoft N; Tilotta MC; Witte AB; Osbak PS; Poulsen SS; Bindslev N; Hansen MB
BMC Gastroenterol; 2010 Jan; 10():9. PubMed ID: 20100359
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.
Lazzari M; Greco MT; Marcassa C; Finocchi S; Caldarulo C; Corli O
Drug Des Devel Ther; 2015; 9():5863-72. PubMed ID: 26586937
[TBL] [Abstract][Full Text] [Related]
7. The effects of amiloride and age on oxygen consumption coupled to electrogenic sodium transport in the human sigmoid colon.
Carra GE; Matus D; Ibáñez JE; Saraví FD
Saudi J Gastroenterol; 2015; 21(5):290-4. PubMed ID: 26458855
[TBL] [Abstract][Full Text] [Related]
8. The impact of naloxegol on anal sphincter function - Using a human experimental model of opioid-induced bowel dysfunction.
Grønlund D; Poulsen JL; Krogh K; Brock C; Liao D; Gregersen H; Drewes AM; Olesen AE
Eur J Pharm Sci; 2018 May; 117():187-192. PubMed ID: 29432808
[TBL] [Abstract][Full Text] [Related]
9. Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.
Etropolski M; Kelly K; Okamoto A; Rauschkolb C
Adv Ther; 2011 May; 28(5):401-17. PubMed ID: 21494892
[TBL] [Abstract][Full Text] [Related]
10. Colonic epithelial ion transport is not affected in patients with diverticulosis.
Osbak PS; Bindslev N; Poulsen SS; Kaltoft N; Tilotta MC; Hansen MB
BMC Gastroenterol; 2007 Sep; 7():37. PubMed ID: 17888183
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
[TBL] [Abstract][Full Text] [Related]
12. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
Kanazawa M; Watanabe S; Tana C; Komuro H; Aoki M; Fukudo S
Neurogastroenterol Motil; 2011 Aug; 23(8):754-e332. PubMed ID: 21615623
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive site-specific whole genome profiling of stromal and epithelial colonic gene signatures in human sigmoid colon and rectal tissue.
Knight JM; Kim E; Ivanov I; Davidson LA; Goldsby JS; Hullar MA; Randolph TW; Kaz AM; Levy L; Lampe JW; Chapkin RS
Physiol Genomics; 2016 Sep; 48(9):651-9. PubMed ID: 27401218
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system: Effect of opioids.
Mark EB; Klinge MW; Grønlund D; Poulsen JL; Schlageter V; Scott SM; Krogh K; Drewes AM
Neurogastroenterol Motil; 2020 Mar; 32(3):e13753. PubMed ID: 31721398
[TBL] [Abstract][Full Text] [Related]
15. Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain.
Kwong WJ; Hammond G; Upmalis D; Okamoto A; Yang M; Kavanagh S
Clin J Pain; 2013 Aug; 29(8):664-72. PubMed ID: 23835764
[TBL] [Abstract][Full Text] [Related]
16. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
[TBL] [Abstract][Full Text] [Related]
17. Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency.
Eichenbaum G; Göhler K; Etropolski M; Steigerwald I; Pergolizzi J; Kim M; Vorsanger G
J Opioid Manag; 2015; 11(3):211-27. PubMed ID: 25985806
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
Hale ME; Dvergsten C; Gimbel J
J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation.
Rentz AM; Yu R; Müller-Lissner S; Leyendecker P
J Med Econ; 2009; 12(4):371-83. PubMed ID: 19912069
[TBL] [Abstract][Full Text] [Related]
20. Enteric RET inhibition attenuates gastrointestinal secretion and motility via cholinergic signaling in rat colonic mucosal preparations.
Russell JP; Mohammadi E; Ligon C; Latorre R; Johnson AC; Hoang B; Krull D; Ho MW; Eidam HS; DeMartino MP; Cheung M; Oliff AI; Kumar S; Greenwood-Van Meerveld B
Neurogastroenterol Motil; 2019 Apr; 31(4):e13479. PubMed ID: 30311722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
